Page 81 - RaRió 9
P. 81

mayo-agosto  -  2020  /  3(9)
                                                               I   81   I




















                                                 accessory protein 4a is a type I interferon antagonist. Journal of Virology, 87(22), 12489-
                                                 12495. doi: 10.1128 / JVI.01845-13

                                          Oudshoorn, D., Rijs, K., Limpens, R. W., Groen, K., Koster, A. J., Snijder, E. J., Kikkert, M., & Bárcena,
                                                 M. (2017). Expression and cleavage of Middle East respiratory syndrome coronavirus
                                                 nsp3-4 polyprotein induce the formation of double-membrane vesicles that mimic those
                                                 associated with coronaviral RNA replication.  MBio, 8(6), e01658-01617. doi: 10.1128/
                                                 mBio.01658-17

                                          Sompayrac, L. M. (2019). How the immune system works. New Jersey: Hoboken.
                                          Tang, N., Li, D., Wang, X., & Sun, Z. (2020). Abnormal coagulation parameters are associated with
                                                 poor prognosis in patients with novel coronavirus pneumonia. Journal of Thrombosis and
                                                 haemostasis, 18, 844-847. doi: 10.1111/jth.14768

                                          Thevarajan, I., Nguyen, T. H., Koutsakos, M., Druce, J., Caly, L., van de Sandt, C. E., Cowie, B. et. al.
                                                 (2020). Breadth of concomitant immune responses prior to patient recovery: a case report
                                                 of non-severe COVID-19. Nature Medicine, 26(4), 453-455. doi: 10.1038/s41591-020-0819-2

                                          Wang, F., Hou, H., Luo, Y., Tang, G., Wu, S., Huang, M., Liu, W., Zhu, Y., Lin, Q., Mao, L., Fang, M.,
                                                 Zhang, H. & Sun, Z. (2020). The laboratory tests and host immunity of COVID-19 patients
                                                 with different severity of illness. JCI insight, 5(10). doi: 10.1172/jci.insight.137799

                                          Wang, J.-Z., Zhang, R.-Y., & Bai, J. (2020). An anti-oxidative therapy for ameliorating cardiac injuries
                                                 of critically ill COVID-19-infected patients. International Journal of Cardiology, 312, 137-
                                                 138. doi: /10.1016 / j.ijcard.2020.04.009
                                          Wathelet, M. G., Orr, M., Frieman, M. B., & Baric, R. S. (2007). Severe acute respiratory syndrome
                                                 coronavirus evades antiviral signaling: role of nsp1 and rational design of an attenuated
                                                 strain. Journal of Virology, 81(21), 11620-11633. doi: 10.1128 / JVI.00702-07

                                          Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C.,  Wang, F.S. et al. (2020). Pathological find-
                                                 ings of COVID-19 associated with acute respiratory distress syndrome. The Lancet Respira-
                                                 tory Medicine, 8(4), 420-422. doi: 10.1016/S2213-2600(20)30076-X

                                          Yang, X., Chen, X., Bian, G., Tu, J., Xing, Y., Wang, Y., & Chen, Z. (2014). Proteolytic processing,
                                                 deubiquitinase and interferon antagonist activities of Middle East respiratory syndrome
                                                 coronavirus papain-like protease. Journal of General Virology, 95(3), 614-626. doi: 10.1099
                                                 / vir.0.059014-0


                                                                                                 La respuesta inmunitaria
                                                                                              frente al virus SARS-CoV-2
                                                                                                      Aguilar & Sánchez
   76   77   78   79   80   81   82   83   84   85   86